Nebennieren

  • B. Allolio
  • P. J. Barth
  • H. Dralle
  • O. Gimm
  • B. Hamberger
  • J. Klose
  • H. Lehnert
  • A. Machens
  • R. Moll
  • J. Mundschenk
  • C. Nies
  • M. Reincke

Zusammenfassung

Die Nebennieren umfassen 2 anatomisch und funktionell unterscheidbare Organe: die Nebennierenrinde und das Nebennierenmark. Beide spielen eine zentrale Rolle in der Streßbewältigung und sind regulativ miteinander verknüpft. Unterfunktionen der Nebennierenrinde können primär (z. B. durch Organzerstörung) oder sekundär durch den Ausfall regulativer Hormone (ACTH, Renin) bedingt sein. Ein Ausfall des Nebennierenmarks ist ohne signifikante klinische Bedeutung. Überfunktionssyndrome der Nebenniere (Cushing-Syndrom, primärer Hyperaldosteronismus, Phäochromozytom) sind oft die Folge monoklonaler adrenaler Tumoren, die in ihrer Mehrzahl benigne sind und zur Suppression der Funktion der intakten kontralateralen und der paraadenomatösen Nebenniere führen können. Sie können auch sekundär durch eine gesteigerte Stimulation der Nebenniere entstehen (z. B. ACTH-abhängiges Cushing-Syndrom). Adrenale Enzymdefekte sind meist durch eine Kombination von Unterfunktion und Überfunktion als Folge der Anhäufung von Steroidhormonvorstufen gekennzeichnet.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Allolio B, Reincke M (1997) Adrenocorticotropin receptor and adrenal disorders. Horm. Res. 47: 273–8Google Scholar
  2. Allolio B, Artl W, Reincke M (1996) Medical therapy of Cushing’s syndrome. In: von Werder K, Fahlbusch R (eds) Pituitary adenomas. Elsevier, Amsterdam, pp 223–229Google Scholar
  3. Allolio B, Ehses W, Steffen HM, Muller R (1994) Reduced lymphocyte beta 2-adrenoceptor density and impaired diastolic left ventricular function in patients with glucocorticoid deficiency. Clin Endocrinol Oxf 40: 769–75PubMedCrossRefGoogle Scholar
  4. Arlt W, Haas JF, Callies M et al. (1999) Biotransformation of oral dehydroepiandrosterone ( DHEA) in elderly men: Significant increase in circulating estrogens. J Clin Endocrinol Metab, (im Druck )Google Scholar
  5. Bamberger CM, Schulte HM, Chrousos GP (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17: 245–61PubMedGoogle Scholar
  6. Beuschlein F, Schulze E, Mora P, Gensheimer HP, MaserGluth C, Allolio B, Reincke M (1998) Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. J Clin Endocrinol Metab 83: 2585–8PubMedCrossRefGoogle Scholar
  7. Beuschlein F, Reincke M, Karl M et al. (1994) Clonal composition of human adrenocortical neoplasms. Cancer Res 54: 4927–4932PubMedGoogle Scholar
  8. Bornstein SR (1996) Phäochromozytom In: Allolio B, Schulte HM (Hrsg): Praktische Endokrinologie. Urban and Schwarzenberg, München, S 266–273Google Scholar
  9. Bravo EL (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15: 356–68PubMedGoogle Scholar
  10. Caron, KM, Clark BJ, Ikeda Y, Parker KL (1997) Steroidogenic factor 1 acts at all levels of the reproductive axis. Steroids 62: 53–56PubMedCrossRefGoogle Scholar
  11. Cato AC, Wade E (1996) Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18: 371–378PubMedCrossRefGoogle Scholar
  12. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL (1984) The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing’s syndrome. N Engl J Med 310: 622–626Google Scholar
  13. Colman SD, Wallace MR (1994) Neurofibromatosis type 1. Eur J Cancer 30: 1974–1981CrossRefGoogle Scholar
  14. De Keyzer, Bertagna YX, Lenne F, Girard F, Luton JP, Kahn A (1985) Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries. J Clin Invest 76: 1892–1898Google Scholar
  15. Dluhy RG, Williams GH (1998) Endocrine Hypertension. In: Wilson, JD, Foster DW, Kronenberg HM, Larsen R (eds) Williams Textbook of Endocrinology, 9th Edition, WB Saunders, Philadelphia, pp 729–750Google Scholar
  16. Dobbie JW (1969) Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99: 1–18PubMedCrossRefGoogle Scholar
  17. Dörr, HG (1996) Adrenogenitales Syndrom. In: Allolio B, Schulte HM (Hrsg) Praktische Endokrinologie. Urban and Schwarzenberg, München, S 247–260Google Scholar
  18. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19: 101–43PubMedCrossRefGoogle Scholar
  19. Estivariz EF, Lowry PJ, Jackson S (1992) Control of adrenal growth. In: James VHT (ed): The adrenal gland. Raven Press, New York, pp 43–70Google Scholar
  20. Funder JW (1995) Mineralocorticoid receptors and hypertension. J Steroid Biochem Mol Biol 53: 53–5PubMedCrossRefGoogle Scholar
  21. Heppner C, Reincke M, Agarwal SKP et al. (1999) MEN 1 Gene Analysis in Sporadic Adrenocortical Neoplasms. J Clin Endocrinol Metab, (im Druck)Google Scholar
  22. Jaresch S, Kley HK, Schlaghecke R (1990) Adrenogenitales Syndrom–Heute eine radiologische Diagnose? Klin Wochenschr 68: 328–331PubMedCrossRefGoogle Scholar
  23. Lacroix A, Bolte E, Tremblay J et al. (1992) Gastric inhibitory polypeptide-dependent cortisol hypersecretion–a new cause of Cushing’s syndrome. N Engl J Med 327: 974–80PubMedCrossRefGoogle Scholar
  24. Latif F, Tory K, Gnarra J et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317–20PubMedCrossRefGoogle Scholar
  25. Latronico AC, Reincke M, Mendonca BB et al. (1995) No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J Clin Endocrinol Metab 80: 875–877PubMedCrossRefGoogle Scholar
  26. Moore TJ, Dluhy RG, Williams GH, Cain JP (1976) Nelson’s syndrome: frequency, prognosis, and effect of prior pituitary irradiation. Ann Intern Med 85: 731–734PubMedGoogle Scholar
  27. Neville AM, O’Hare MJ (1979) Aspects of structure, function and pathology. In: James VHT (ed): The adrenal gland Raven Press, New York, pp 1–65Google Scholar
  28. Oelkers W, Bähr V (1993) Funktionelle Aspekte der Zonierung der Nebennierenrinde. In: Schulte HM, Benker G, Allolio B (Hrsg): Therapie mit Glukokortikoiden. Schattauer, Stuttgart, S 69–79Google Scholar
  29. Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321: 492–6PubMedCrossRefGoogle Scholar
  30. Oelkers W (1991) System Hypothalamus-HypophyseNebenniere. In: Hierholzer K, Schmidt RF (Hrsg) Pathophysiologie des Menschen. VCH, Weinheim S 19.1519. 22Google Scholar
  31. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551–555PubMedCrossRefGoogle Scholar
  32. Orth DN, Kovacs WJ (1998) The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, Larsen R (eds) Williams Textbook of Endocrinology, 9th edition, WB Saunders, Philadelphia, pp 517–664Google Scholar
  33. Reincke M, Allolio B (1997) Molekularbiologie der zufällig diagnostizierten Nebennierenraumforderung. Zentralbl Chir 122: 430–437PubMedGoogle Scholar
  34. Reincke M (1998) Mutations in adrenocortical tumors. Horm Metab Res 30: 447–455PubMedCrossRefGoogle Scholar
  35. Rosner W (1990) The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev Il: 80–91Google Scholar
  36. Sachse R, Shao XJ, Rico A, Finckh U, Rolfs A, Reincke M, Hensen J (1997) Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors. Eur J Endocrinol 137: 262–266PubMedCrossRefGoogle Scholar
  37. Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU (1991) Clonal composition of pituitary adenomas in patients with Cushing’s disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 73: 1302–1308PubMedCrossRefGoogle Scholar
  38. Stocco DM, Clark BJ (1996) Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 17: 221–244PubMedGoogle Scholar
  39. Strohm M, Reineke M, Theiss M, Diehl KL, Allolio B (1994) Bilateral massive macronodular adrenal gland hyperplasia. A rare cause of Cushing’s syndrome. Dtsch Med Wochenschr 119: 180–184Google Scholar
  40. Toth MK, Râcz V, Adleff 1 et aI. (1999) Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy. Eur J Endocrinol, (im Druck)Google Scholar
  41. Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ (1994) Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab 78: 323–328PubMedCrossRefGoogle Scholar
  42. Young JB, Landsberg L (1998) Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW, Kronenberg HM, Larsen R (eds) Williams Textbook of Endocrinology, 9th edition, WB Saunders, Philadelphia, pp 665728Google Scholar
  43. Zanaria E, Muscatelli F, Bardoni B et al. (1994) An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372: 635–641PubMedCrossRefGoogle Scholar
  44. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P (1997) DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature, 390: 311–315PubMedCrossRefGoogle Scholar
  45. Bonier HJ, Lange JF, Kazemier G, de Herder WW, Steyerberg EW, Bruining HA (1997) Comparison of three techniques for adrenalectomy. Br. J. Surg 84: 679–682Google Scholar
  46. Brunt LM, Doherty GM, Norton JA, Soper NJ, Quasebarth MA, Moley JF (1996) Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 183: 1–10PubMedGoogle Scholar
  47. Buell JF, Alexander HR, Norton JA, Yu KC, Fraker DL (1997) Bilateral adrenalectomy for Cushing’s syndrome–anterior versus posterior surgical approach. Ann Surg 225: 63–68PubMedCrossRefGoogle Scholar
  48. Fernandez-Cruz L, Benarroch G, Torres E, Martinez-Martin M, Saenz A (1993) Laparoscopic removal of an adrenocortical adenoma. Br J Surg 80: 874PubMedCrossRefGoogle Scholar
  49. Fernandez-Cruz L, Saenz A, Benarroch G, Astudillo E, Taura P, Sabater L (1996) Laparoscopic unilateral and bilateral adrenalectomy for Cushing’s syndrome–transperitoneal and retroperitoneal approaches. Ann Surg 224: 727–736PubMedCrossRefGoogle Scholar
  50. Gagner M, Lacroix A, Boité E (1992) Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327: 1033PubMedCrossRefGoogle Scholar
  51. Grant CS. (1997) Pheochromocytoma. In: Clark OH, Duh QY (eds) Textbook of Endocrine Surgery. W. B. Saunders Company, Philadelphia London Toronto Montreal Sydney Tokio, pp 513–522Google Scholar
  52. Guazzoni G, Montorsi F, Bocciardi A, da Pozzo L, Rigatti P, Lanzi R, Pontiroli A (1995) Transperitoneal laparoscopic versus open adrenalectomy for benign hyperfunctioning adrenal tumors: A comparative study. J Urol 153: 1597–1600Google Scholar
  53. Heintz A, Junginger T (1994) Die endoskopische, extraperitoneale Adrenalektomie. Chirurg 65: 1140–1142PubMedGoogle Scholar
  54. Heintz A, Walgenbach S, Junginger T (1996) Results of endoscopie retroperitoneal adrenalectomy. Surg Endosc 10: 633–635PubMedCrossRefGoogle Scholar
  55. Linos DA, Stylopoulos N, Boukis M, Souvatzoglou A, Raptis S, Papadimitriou J (1997) Anterior, posterior, or laparoscopic approach for the management of adrenal diseases ? Am J Surg 173: 120–125PubMedCrossRefGoogle Scholar
  56. MacGillivray DC, Shichman SJ, Ferrer FA, Malchoff CD (1996) A comparison of open vs laparoscopic adrenalectomy. Surg Endosc 10: 987–990PubMedCrossRefGoogle Scholar
  57. Möbius E, Nies C, Rothmund M (1999) Surgical treatment of pheochromocytomas: Laparoscopic or conventional ? Surg. Endosc 13: 35–39Google Scholar
  58. Monkhouse WS, Khalique A (1986) The adrenal and renal veins of man and their connections with azygos veins. J Anat 146: 105–115PubMedGoogle Scholar
  59. Naito S, Uozumi J, Ichimiya H et al. (1994) Laparoscopic adrenalectomy: Comparison with open adrenalectomy. Eur Urol 26: 253–257Google Scholar
  60. Nies C, Möbius E, Rothmund M (1997) Laparoskopische Nebennierenchirurgie. Chirurg 68: 99–106PubMedCrossRefGoogle Scholar
  61. Prinz RA (1995) A comparison of laparoscopic and open adrenalectomies. Arch Surg 130: 489–494PubMedCrossRefGoogle Scholar
  62. Russell CF, Hamberger B, van Heerden JA, Edis AJ, Ilstrup DM (1982) Adrenalectomy: Anterior or posterior approach ? Am J Surg 144: 322–325PubMedCrossRefGoogle Scholar
  63. Thornton JK (1890) Abdominal nephrectomy for large sarcoma of the left suprarenal capsule: Recovery. Trans Clin Soc. London 23: 150–153Google Scholar
  64. Young HH (1936) A technique for simultaneous exposure and operation on the adrenals. Surg gynecol Obstet 63: 179–188Google Scholar
  65. Walz MK, Peitgen K, Krause U, Eigler FW (1995) Die dorsale retroperitoneoskopische Adrenalektomie - eine neue operative Technik. Zentralbl. Chir 120: 53–58Google Scholar
  66. Welbourn RB (1990) The Adrenal Glands. In: Welbourn RB (ed) The History of Endocrine Surgery. Praeger, New York, Westport ( Connecticut ), London, pp 147–210Google Scholar
  67. Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma. Analysis of 1.000 autopsied cases. Cancer 3: 74–85PubMedCrossRefGoogle Scholar
  68. Achilles E, Padberg BC, Holl K, Klöppel G, Schröder S (1991) Immuncytochemistry of paragangliomas–value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 18: 453–458PubMedCrossRefGoogle Scholar
  69. Aguilo F, Tamayo N, Vazquez-Quintana E et al. (1991) Pheochromocytoma: a twenty year experience at the University Hospital. PR Heath Sci J 10: 135–142Google Scholar
  70. Aiba M, Hirayama A, Iri H et al. (1991) Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing’s syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol 96: 334–340Google Scholar
  71. Bove KE, McAdams AJ (1981) Composite ganglioneuroblastoma. An assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy. Arch Pathol Lab Med 105: 325–330Google Scholar
  72. Brabrand K, Soreide JA (1987) Adrenal cortical carcinoma with invasion into the inferior vena cava. Br J Surg 74: 598–599PubMedCrossRefGoogle Scholar
  73. Carney JA, Sizemore GW, Tyce GM (1975) Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2: the precursor of bilateral pheochromocytoma. Mayo Clin Proc 50: 3–10PubMedGoogle Scholar
  74. Cohn K, Gottesman L, Brennan M (1986) Adrenocortical carcinoma. Surgery 100: 1170–1177PubMedGoogle Scholar
  75. Correa P, Chen VW (1995) Endocrine gland cancer. Cancer 75: 338–352PubMedCrossRefGoogle Scholar
  76. Cote RJ, Cordon-Cardo C, Reuter VE, Rosen PP (1990) Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastics conversion in the adrenal cortex. Am J Pathol 136: 1077–1084Google Scholar
  77. D’Agata R, Malozowski S, Barkan A, Cassorla F, Loriaux D (1987) Steroid biosynthesis in human adrenal tumors. Horm Metabol Res 19: 386–388CrossRefGoogle Scholar
  78. DeLellis RA, Suchow E, Wolfe HJ (1980) Ultrastructure of nuclear inclusions in pheochromocytoma and paraganglioma. Hum Pathol 11: 205–207PubMedCrossRefGoogle Scholar
  79. Dhom G (1981) Die Nebennierenrinde. In: Doerr W, Seifert G (Hrsg) Spezielle pathologische Anatomie, Bd. 14/2: Pathologie der endokrinen Organe. Springer, Berlin, S 729–970Google Scholar
  80. Dobbie JW (1969) Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99: 1–18PubMedCrossRefGoogle Scholar
  81. Enzinger FM, Weiss SW (1995) Soft tissue tumors. CV Mosby, St. Louis, pp 828–831Google Scholar
  82. Evans AE, D’Angio GJ, Randolph J (1971) A proposed staging for children with neuroblastoma. Children’s Cancer Study Group A. Cancer 27: 374–378Google Scholar
  83. Gaffey MJ, Traweek ST, Mills SE, Travis WD, Lack EE, Medeiros LJ, Weiss LM (1992) Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 23: 144–153PubMedCrossRefGoogle Scholar
  84. Haak HR, Fleuren GJ (1995) Neuroendocrine differentia- tion of adrenocortical tumors. Cancer 75: 860–864PubMedCrossRefGoogle Scholar
  85. Hachitanda Y, Tsuneyoshi M, Enjoji M (1989) Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuronspecific enolase, chromogranin, and synaptophysin. Arch Pathol Lab Med 11: 381–384Google Scholar
  86. Henley DJ, van Heerden JA, Grant CS, Carney JA, Carpenter PC (1983) Adrenal cortical carcinoma–a continuing challenge. Surgery 94: 926–931PubMedGoogle Scholar
  87. Hume DM (1960) Pheochromocytoma in the adult and in the child. Am J Surg 99: 458–496PubMedCrossRefGoogle Scholar
  88. Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 41: 572–580PubMedCrossRefGoogle Scholar
  89. Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C (1992) Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 112: 972–980PubMedGoogle Scholar
  90. Jackson R, McNicol AM, Farquharson M, Foulis AK (1988) Class II MHC expression in normal adrenal cortex and cortical cells in autoimmune Addison’s disease. J Pathol 155: 113–120PubMedCrossRefGoogle Scholar
  91. Joshi VV, Cantor AB, Altshuler G et al. (1992) Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69: 2197–2211PubMedCrossRefGoogle Scholar
  92. King DR, Lack EE (1979) Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 44: 239244Google Scholar
  93. Klöppel G (1997) Nebennierenmark. In: Remmele W (Hrsg) Pathologie, Bd. 4, 2. Auflage. Springer, Berlin, S 654–658Google Scholar
  94. Kumar D, Kumar S (1993) Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis. Mod Pathol 6: 36–41PubMedGoogle Scholar
  95. Lack EE (1994) Pathology of adrenal and extra-adrenal paraganglia. In: Major problems in pathology, Vol 29. WB Saunders, PhiladelphiaGoogle Scholar
  96. Lack EE (1997a) Tumors of the adrenal gland and extra-adrenal paraganglia. Atlas of tumor pathology, 3rd series, fascicle 19. Armed Forces Institute of Pathology, Washington D.C., pp 1–468Google Scholar
  97. Lack EE (1997b) Pathology of the adrenal cortex. In: Lechago J, Gould VE (eds.) Bloodworth’s endocrine pathology, 3rd ed. Williams and Wilkins, Baltimore, pp 355–415Google Scholar
  98. Lack EE, Kozakewich HPW (1990) Embryology, developmental anatomy, and selected aspects of non-neoplastic pathology. In: Lack EE (ed) Pathology of the adrenal glands. Churchill Livingstone, New York, pp 1–74Google Scholar
  99. Lack EE, Mulvihill JJ, Travis WD, Kozakewich HP (1992) Adrenal cortical neoplasms in the pediatric and adolescent age group. Clinicopathological study of 30 cases with emphasis on epidemiological and prognostic factors. Pathol Annu 27: 1–53PubMedGoogle Scholar
  100. Linnoila RI, Keiser HR, Steinberg SM, Lack EE (1990) Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21: 1168–1180PubMedCrossRefGoogle Scholar
  101. Lloyd RV (1997) Adrenal medulla and paraganglia. In: Lechago J, Gould VE (eds.) Bloodworth’s endocrineGoogle Scholar
  102. pathology, 3rd ed. Williams and Wilkins, Baltimore, pp 417–461Google Scholar
  103. Medeiros LJ, Michie SA, Johnson DE, Warnke RA, Weis LM (1988) An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type and histologic pattern. Hum Pathol 19: 980–937PubMedCrossRefGoogle Scholar
  104. MiettInen M, Lehto VP, Virtanen I (1985) Immunofluorescence microscopic evaluation of the intermediate filament expression of the adrenal cortex and medulla and their tumors. Am J Pathol 118: 360–366PubMedGoogle Scholar
  105. Misugi K, Aoki I, Kikyo S, Sasaki Y, Tsunoda A, Nakajima T (1985) Immunohistochemical study of neuroblastoma and related tumors with anti-S-100 protein antibody. Pediat Pathol 3: 217–226CrossRefGoogle Scholar
  106. Nader S, Hickey RC, Sellin RV, Samaan NA (1983). AdrenalGoogle Scholar
  107. cortical carcinoma. A study of 77 cases. Cancer 52: 707711Google Scholar
  108. Nakano M (1988) Adrenal cortical carcinoma. A clinicopathological and immunohistochemical study of 91 autopsy cases. Acta Pathol Jpn 38: 163–180PubMedGoogle Scholar
  109. Neblett WW, Frexes-Steed M, Scott HW Jr. (1987) Experience with adrenocortical neoplasms in childhood. Am Surg 53: 117–125PubMedGoogle Scholar
  110. Neville AM, O’Hare MJ (1985) Histopathology of the human adrenal cortex. Clin Endocrino] Metab 14: 791–820CrossRefGoogle Scholar
  111. Neville AM, Symington T (1966) Pathology of primary aldosteronism. Cancer 19: 1854–1868PubMedCrossRefGoogle Scholar
  112. Pagani A, Forni M, Tonini GP, Papotti M, Bussolati G (1992) Expression of members of the chromogranin family in primary neuroblastomas. Diagn Mol Pathol 1: 16–24PubMedCrossRefGoogle Scholar
  113. Reinhard C, Saeger W, Schubert B (1996) Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gener Diagn Pathol 141: 203–208Google Scholar
  114. ReMine WH, Chong GC, van Heerden JA, Sheps SG, Harrison EG Jr. (1974) Current management of pheochromocytoma. Ann Surg 179: 740–747PubMedCrossRefGoogle Scholar
  115. Ritchey ML, Kinard R, Novicki DE (1987) Adrenal tumors: involvement of the inferior vena cava. J Urol 138: 11341136Google Scholar
  116. Rosen EM, Cassady JR, Frantz CN, Kretschmar C, Levey R, Sallan SE (1984) Neuroblastoma: the Joint Center for radiation therapy/Dana-Farbar Cancer In stitute/Children’s Hospital experience. J Clin Oncol 2: 719–732PubMedGoogle Scholar
  117. Saeger W (1997) Nebennierenrinde. In: Remmele W (Hrsg) Pathologie, Bd. 4, 2. Aufl. Springer, Berlin, S 629–653Google Scholar
  118. Sahagian-Edwards A, Holland JF (1954) Metastatic carcinoma to the adrenal glands with cortical hypofunction. Cancer 7: 1242–1245PubMedCrossRefGoogle Scholar
  119. Schimke RN (1983) The multiple endocrine neoplasia syndromes. In: Humphry GB, Grindey GB, Dehner LP, Actors RT, Pysher TJ (eds) Adrenal and endocrine tumors in children. Martinus Nijhoff, Boston, pp 249264Google Scholar
  120. Schröder S, Niendorf A, Achilles E et al. (1990) Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11. Virchows Arch A Pathol Anat 417: 89–96CrossRefGoogle Scholar
  121. Schröder S, Padberg BC, Achilles E, Holl K, Dralle H, Klöppel G (1992) Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms. Virchows Archiv A Pathol Anat 420: 65–70CrossRefGoogle Scholar
  122. Shenoy BV, Carpenter PC, Carney JA (1984) Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg; Pathol 8: 335–344Google Scholar
  123. Shimada H, Chatten J, Newton WA Jr. et al. (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and agelinked classification of neuroblastomas. J Natl Cancer Inst 73: 405–416PubMedGoogle Scholar
  124. Stackpole RH, Melicow MM, Uson AC (1963) Pheochromocytoma in children. Report of 9 cases and review of the first 100 publishing cases with follow-up studies. J Pediatr 63: 315–330CrossRefGoogle Scholar
  125. Sullivan M, Boileau M, Hodges CV (1978) Adrenal cortical carcinoma. J Urol 120: 660–665PubMedGoogle Scholar
  126. Tang CK, Gray GF (1975) Adrenocortical neoplasms. Prognosis and morphology. Urology 5: 691–695Google Scholar
  127. Tartour E, Caillou B, Tenenbaum F, Schröder S, Luciani S, Talbot M, Schlumberger M (1993) Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody. Cancer 72: 3296–3303PubMedCrossRefGoogle Scholar
  128. Tsuchida Y, Yokomori K, Saito S, Kaku H, Bessho F (1984) Stage IV-S neuroblastoma involving the liver and ectopic liver. Report of an unusual case. Cancer 53: 1609–1611Google Scholar
  129. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA (1989) Adrenal cortical carcinoma. Cancer 64: 765–769PubMedCrossRefGoogle Scholar
  130. Wadih GE, Nance KV, Silverman JF (1992) Fine needle aspiration cytology of the adrenal gland. Fifty biopsies in 48 patients. Arch Pathol Lab Med 116: 841–846PubMedGoogle Scholar
  131. Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8: 163–169PubMedCrossRefGoogle Scholar
  132. Weiss LM, Medeiros LJ, Vickera AL Jr. (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202–206PubMedCrossRefGoogle Scholar
  133. Wick MR, Cherwitz DL, McGlennan RC, Dehner LP (1986) Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Am J Pathol 122: 343–352Google Scholar
  134. Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72: 3145–3155Google Scholar
  135. Young JL Jr., Ries LG, Silverberg E, Horm JW, Miller RW (1986) Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58: 598–602PubMedCrossRefGoogle Scholar
  136. Zerbini C, Kozakewich HP, Weinberg DS, Mundt DJ, Edwards JA III, Lack EE (1992) Adrenocortical neoplasms in childhood and adolescence: analysis of prognostic factors including DNA content. Endocr Pathol 3: 116–128CrossRefGoogle Scholar
  137. Allolio B (1996) Prinzipien endokrinologischer Funktionsdiagnostik. In: Allolio B, Schulte HM (Hrsg) Praktische Endokrinologie, Urban and Schwarzenberg, München S 7–11Google Scholar
  138. Allolio B, Deuß U, Kaulen D, Feltes G, Kosse P, Winkelmann W (1986) Verbesserte ambulante Diagnostik von Nebennierenrinden- ( NNR-) Erkrankungen durch Messung von Kortisol im Speichel. Akt Endokr Stoff 7: 140–144Google Scholar
  139. Arlt W, Justl HG, Callies F et al. (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics und peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83: 1928–1934PubMedCrossRefGoogle Scholar
  140. Benker G, Schulte HM, Günther RW, Reinwein D (1990) Diagnostische Strategien beim Cushing-Syndrom. In: Allolio B, Schulte HM (Hrsg) Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart, S 74–90Google Scholar
  141. Bravo EL (1994) Evolving concept in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15: 356–368PubMedGoogle Scholar
  142. Crapo L (1979) Cushing’s syndrome: a review of diagnostic tests. Metabolism 28: 955PubMedCrossRefGoogle Scholar
  143. Doppman JL (1993) The dilemma of bilateral adrenocortical nodularity in Conn’s and Cushing’s syndromes. Radiol Clin North Am 31 /5: 1039–1050PubMedGoogle Scholar
  144. Griffin JE (1993) Dynamic tests of endocrine function. In: Wilson JD, Foster DW (eds) Textbook of endocrinology, 8th edition. W. B. Saunders, Philadelphia, pp 1663–1670Google Scholar
  145. Laudat MH, Billaud L, Thompoulos P, Vera 0, Yllia A, Luton JP (1988) Evening urinary free corticoids: a screening test in Cushing’s syndrome and incidentally discovered adrenal tumours. Acta Endocrinol (Copenh) 119: 459–464Google Scholar
  146. Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML (1983) Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocr 57: 892–896PubMedCrossRefGoogle Scholar
  147. Oelkers, WKH (1996) Diagnostische Methoden bei Nebennierenerkrankungen. In: Allolio B, Schulte HM (Hrsg): Praktische Endokrinologie, Urban and Schwarzenberg, S 212–218Google Scholar
  148. Oelkers W, Holzhäuer H (1990) Hypertonie durch Hypersekretion von Mineralokortikoiden. In: Allolio B, Schulte HM (Hrsg): Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart, S 40–52Google Scholar
  149. Orth DN, Kovacs WJ (1998) The adrenal contex. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds): Williams Textbook of Endocrinology, 9th edition. W. B. Saunders, Philadelphia, pp 517–664Google Scholar
  150. Young WF Jr, Hogan MJ (1994) Renin-independent hypermineralocorticoidism. Trends Endocr Metab 5: 97–106CrossRefGoogle Scholar
  151. Young JB, Landsberg L (1998) Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams Textbook of Endocrinology, 9th edition. W. B. Saunders, Philadelphia, pp. 665728Google Scholar
  152. Ziegler R, Pickardt CR, Willig RP (1993) Deutsche Gesellschaft für Endokrinologie: Rationelle Diagnostik in der Endokrinologie. Thieme, Stuttgart New YorkGoogle Scholar
  153. Baker ME, Spritzer C, Blinder R, Herfkens RJ, Leight GS, Dunnick NR (1987) Benign adrenal lesions mimicking malignancy on MR imaging: Report of two cases. Radiology 163: 669Google Scholar
  154. Bernardino ME, Walter McCM, Phillips VM et al. (1985) CT-guided adrenal biopsy: accuracy, safety and indications. AJR 144: 67PubMedGoogle Scholar
  155. Berland LL, Koslin DB, Kenney PJ, Stanley RJ, Lee LY (1988) Differentiation between small benign and malignant adrenal masses with dynamic incremented CT. AJR 151: 95PubMedGoogle Scholar
  156. Bilbey JH, McLoughlin RF, Kurkjian PS, Wilkins GEL, Chan NHL, Schmidt N, Singer J (1995) MR Imaging of adrenal masses: Value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR 164: 637–642Google Scholar
  157. Booth GL, Redelmeier DA, Grosman H, Kovacs K, Smyth HS, Ezzat S (1998) Improved diagnostic accuracy of inferior pertrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing’s disease. J Clin Endocrin Metab 83: 2291–2295CrossRefGoogle Scholar
  158. Brady TM, Gross BH, Glazer GM, Williams DM (1985) Adrenal pseudomasses due to varices: AngiographicCT-MRI-pathologic correlations. AJR 145: 301–304Google Scholar
  159. Brueckel J, Boehm BO (1998) Crisis after angiography. Lancet 352: 1278PubMedCrossRefGoogle Scholar
  160. Choyke PL (1998) From needles to numbers: can non-invasive imaging distuinguish benign and malignant adrenal lesions? World J Urol 16: 29–34PubMedCrossRefGoogle Scholar
  161. Cohen, EK, Daneman A, Stringer DA, Soto G, Thorner P (1986) Focal adrenal hemorrhage: A new US appearance. Radiology 161: 631Google Scholar
  162. Cordes K, Georgi M, Günther R, Beyer J (1979) Adrenale and extraadrenale Phäochromocytome. DMW 104: 317CrossRefGoogle Scholar
  163. Dammann F, Wehrmann M, Rieber A (1995) Hämangiom der Nebenniere: Korrelation von CT, MRT and Histologie in einem Fallbericht. Fortschr Röntgenstr 162: 353–355Google Scholar
  164. Dietrich RB, Kangarloo H, Lenarsky C, Feig SA (1987) Neuroblastoma: The role of MR imaging. AJR 148: 937Google Scholar
  165. Doppmann JL, Reinig JW, Dwyer AJ, Frank JP, Norton J, Loriaux L, Keiser H (1987) Differentiation of adrenal masses by magnetic resonance imaging. Surgery 102: 1018–1025Google Scholar
  166. Doppmann JL, Miller DL, Dwyer AJ et al. (1988) Macronodular adrenal hyperplasia in Cushing disease. Radiology 166: 347–352Google Scholar
  167. Doppmann JL, Nieman L,Travis WD, Miller DL, Cutler GB Jr, Chrousos GP, Norton JA (1991) CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. JCAT 15: 773–779Google Scholar
  168. Dunnick NR, Heaston D, Halvorsen R, Moore AV, Korobkin M (1982a) CT appearance of adrenal cortical carcinoma. JCAT 6: 978–982Google Scholar
  169. Dunnick NR, Doppmann JL, Gill JR, Strott CA, Keiser HR, Brennan MF (19826) Localization of functional adrenal tumors by computed tomography and venous sampling. Radiology 142: 429Google Scholar
  170. Dunnick NR, Leight GS Jr, Roubidoux MA, Leder RA, Paulson E, Kurylo L (1993) CT in the diagnosis of primary aldosteronism: Sensitivity in 29 patients. AJR 160: 321324Google Scholar
  171. Ferrozzi F, Bova D (1995) CT and MR demonstration of fat within adrenal cortical carcinoma. Abdom Imaging 20: 272–274PubMedCrossRefGoogle Scholar
  172. Francis I, Glazer GM, Dshapiro B, Sisson JC, Gross BH (1983) Complementary roles of CT and 131-J-MIBG scintigraphy in diagnosing pheochromocytoma. AJR 141: 719PubMedGoogle Scholar
  173. Georgi M, Wetzel E, Drescher P, Schmidt R (1989) Aktuelle Entwicklungen in der radiologischen Nebennierendiagnostik. Radiologe 29: 23–31PubMedGoogle Scholar
  174. Ghiatas AA, Chopra S, Schnitker JB (1996) Is sonographic flow imaging useful in the differential diagnosis of adrenal masses? Brit J Radiol 69: 1005–1008PubMedCrossRefGoogle Scholar
  175. Grant CS, Carney JA, Carpenter PC, van Heerden JA (1986) Primary pigmented nodular adrenocortical disease: diagnosis and management. Surgery 100: 1178–1183PubMedGoogle Scholar
  176. Günther R, Kelbel C, Lenner V (1984) Real-time ultrasound of normal adrenal glands and small tumours. J Clin Ultrasound 12: 211–217PubMedCrossRefGoogle Scholar
  177. Hauser H, Gurret JP (1986) Miliary tuberculosis associated with adrenal enlargement: CT appearance. JCAT 10: 254Google Scholar
  178. Hibi S, Todo S, Imashuku S, Miyazaki T (1987) 131-J-Metaiodobenzylguanidine scintigraphy in patients with neuroblastoma. Pediatr Radiol 17: 308Google Scholar
  179. Howlett TA, Drury PL, Perry L (1986) Diagnosis and management of ACTH-dependant Cushing’s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol 24: 699–713CrossRefGoogle Scholar
  180. Huebener KH, Treugut H (1984) Adrenal cortes dysfunction. CT findings. Radiology 150: 195Google Scholar
  181. Kahaly G, Krause U, Ritthaler H, Cordes U, Günther R, Schrezenmeir J, Beyer J (1985) Selective blood sampling in adrenal hypertension, Cardiology 72 /1: 179–181PubMedCrossRefGoogle Scholar
  182. Kier R, McCarthy S. (1989) MR characterization of adrenal masses: field strength and pulse sequence considerations. Radiology 171: 671PubMedGoogle Scholar
  183. Klose KC, Andreopoulos D, Adam G, Biesterfeld S (1992) Hypervaskularisiertes Nebennierenrindenadenom. Ein differentialdiagnostisches Problem in der dynamischen CT and MRT. Radiologe 32: 32–35Google Scholar
  184. Klöppel G (1984) Nebennierenmark. In: Remmele W (Hrsg) Pathologie. Ein Lehr-and Nachschlagebuch, Band 3. Springer-Verlag, Berlin Heidelberg New York Tokyo, S 467–475Google Scholar
  185. Krestin GP, Friedmann G, Fischbach R, Neufang KFR, Allolio B (1991) Evaluation of adrenal masses in oncologie patients: Dynamic contrast-enhanced MR vs CT. JCAT 15: 104–110Google Scholar
  186. Leroy-Willig A, Bittoun J, Luton JP (1989) In vivo MR spectroscopic imaging of the adrenal glands: Distinction between adenomas and carcinomas larger than 15 mm based on lipid content. AJR 153: 771–773PubMedGoogle Scholar
  187. Ling D, Korobkin M, Silverman PM, Dunnick NR (1983) CT demonstration of bilateral adrenal hemorrhage. AJR 141: 307PubMedGoogle Scholar
  188. McCorkell SJ, Niles NL (1985) Fine-needle aspiration of catecholamine-producing adrenal masses: A possible fatal mistake. AJR 145: 113Google Scholar
  189. Miles JM, Wahner HW, Carpenter PC, Salassa RM, Northcutt RC (1979) Adrenal scintiscanning with NP 59, a new radioiodinated cholesterol agent. Mayo Clin Proc 54: 321PubMedGoogle Scholar
  190. Miyake H, Maeda H, Tashiro M et al. (1989) CT of adrenal tumors: Frequency and clinical significance of low-attenuation lesions. AJR 152: 1005–1007Google Scholar
  191. Murphy BJ, Casillas J, Yrizarry JM (1988) Traumatic adrenal hemorrhage; Radiological findings. Radiology 169: 701–703Google Scholar
  192. Musante F, Derchi LE, Bazzocchi M, Avataneo T, Gandini G, Pozzi Mucelli RS (1991) MR imaging of adrenal myelolipomas. JCAT 15: 111–114Google Scholar
  193. Neumann HPH, Berger DP, Sigmund G et al. (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329: 1531–1538PubMedCrossRefGoogle Scholar
  194. Nimkin K, Teeger S, Wallach MT, DuVally JC, Spevak MR, Kleinmann PK (1994) Adrenal hemorrhage in abused children: Imaging and postmortem findings. AJR 162: 661–663Google Scholar
  195. Noble MJ, Montaggue DK, Levin HS (1982) Myelolipoma: An unusual surgical lesion of the adrenal gland. Cancer 49: 952Google Scholar
  196. O’Brien WM, Choyke PL, Copeland J, Klappenbach RS, Lynch JH (1987) Computed tomography of adrenal abscess. JCAT 11: 550Google Scholar
  197. Pagani, JJ (1984) Non-small cell lung carcinoma adrenal metastases. Computed tomography and percutaneous needle biopsy in their diagnosis. Cancer 53: 1058–1060Google Scholar
  198. Paling MR, Williamson BRJ (1983) Adrenal involvement in non-Hodgkin lymphoma. AIR 1983: 303Google Scholar
  199. Provenzale JM, Ortel TL, Nelson RC (1995) Adrenal hemorrhage in patients with primary antiphospholipid syndrome: Imaging findings. AJR 165, 361–364Google Scholar
  200. Premkuwar A, Chow CK, Choyke PL, Doppmann JL (1992) Stress-induced adrenal hyperplasia simulating metastastic disease: CT and MR findings. AIR 159: 675–676Google Scholar
  201. Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL (1987) Pheochromocytoma and paraganglioma: Comparison of MR imaging with CT and J-131-MIBG scintigraphy. Radiology 165: 89PubMedGoogle Scholar
  202. Sample WF (1978) Adrenal ultrasonography. Radiology 127: 461PubMedGoogle Scholar
  203. Seddon JM, Baranetzsky N, VanBoxel PJ (1985) Adrenal „incidentalomas“. Urology 25: 1PubMedCrossRefGoogle Scholar
  204. Schwartz LH, Panicek DM, Doyle MV et al. (1997) Comparison of two algorithms and their associated charges when evaluating adrenal masses in patients with malignancies. AJR 168: 1575–1578PubMedGoogle Scholar
  205. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwalters WH (1985) Iodine-131-metaiodobenzylguanidine for the locating of suspected pheochromocytoma: Experience in 400 cases. J Nucl Med 26: 576PubMedGoogle Scholar
  206. Sörensen R, Moltz L (1981) Diagnostik beim progredienten Hirsutismus. Kathetertechnik and Ergebnisse. Röfo 135: 257Google Scholar
  207. Stark DD, Moss AA, Brasch RC (1983a) Neuroblastoma. Diagnostic imaging and staging. Radiology 148: 101Google Scholar
  208. Stark DD, Moss AA, Brasch RC (1983b) Recurrent neuroblastoma: The role of CT and alternative imaging tests. Radiology 148: 107Google Scholar
  209. Van Erkel AR, van Gils APG, Lequin M, Kruitwagen C, Bloem JL, Falke THM (1994) CT and MR distinction of adenomas and nonadenomas of the adrenal gland. JCAT 18: 432–438Google Scholar
  210. Vincent JM, Morrison ID, Armstrong P, Reznek RH (1994a) The size of normal adrenal gland on computed tomography. Clinical Radiology 49: 453–455PubMedCrossRefGoogle Scholar
  211. Vincent JM, Morrison ID, Armstrong P, Reznek RH (1994b) Computed tomography of diffuse, non-metastatic enlargement of the adrenal glands in patients with malignant disease. Clinical Radiology 49: 456–460PubMedCrossRefGoogle Scholar
  212. Welch TJ, Sheedy PF, Johnson CM, Stephens DH (1989) CT-guided biopsy: Prospective analysis of 1 000 procedures. Radiology 171: 493PubMedGoogle Scholar
  213. Wilson DA, Muchmore HG, Tisdal RG, Fahmy A, Pitha JV (1984) Histoplasmosis of the adrenal glands studied by CT. Radiology 150: 779PubMedGoogle Scholar
  214. Yeh H (1980) Sonography of the adrenal glands and small masses. AJR 135: 1167PubMedGoogle Scholar
  215. Zimmermann GG, Debatin JF, Krestin GP (1997) Differenzierung von Nebennierentumoren: Verbesserung der Treffsicherheit durch Kombination fettsensitiver, T2 gewichteter and kontrastverstärkter MR-Sequenzen. Fortschr. Röntgenstr. 167: 153–159Google Scholar
  216. Edis AJ, Grant CS, Egdahl RH (1984) Manual of endocrine surgery. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  217. Gagner M, Lacroix A, Bolte E (1992) Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327: 1033PubMedCrossRefGoogle Scholar
  218. Grant CS (1997) Pheochromocytoma. In: Clark OH, Duh YQ (eds) Textbook of endocrine surgery. WB Saunders, PhiladelphiaGoogle Scholar
  219. Lack EE (1997) Tumors of the adrenal gland and extra-adrenal paraganglia. Armed Forces Institute of Pathology, Washington D. C.Google Scholar
  220. Möbius E, Nies C, Rothmund M (1999) Surgical treatment of pheochromocytomas. Surg Endosc 13: 35–39PubMedCrossRefGoogle Scholar
  221. Nies C, Bartsch D, Schäfer U, Rothmund M (1993) Laparoskopische Adrenalektomie. Dtsch Med Wschr 118: 1831–1836PubMedCrossRefGoogle Scholar
  222. Scott HW, JR. The panic syndrome: pheochromocytoma surgical endocrinology, Clinical syndromes (1990) In: Friesen SR, Thompson NW (eds) J B Lippincott Company, Philadelphia, pp 163–180Google Scholar
  223. Walz MK, Peitgen K, Hoermann R, Giebler RM et al. (1996) Posterior retroperitoneoscopy as a new minimally invasive approach for adrenalectomy: results of 30 adrenalectomies in 27 patients. World J Surg 20: 769–774PubMedCrossRefGoogle Scholar
  224. Averbuch SD, Steakley CS, Young RC et al. (1988) Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine an darcabazine. Ann Intern Med 109: 267–273Google Scholar
  225. Boland GW, Lee MJ (1995) Magnetic resonance imaging of the adrenal gland. Crit Rev Diagn Imaging 36: 115–174PubMedGoogle Scholar
  226. Bravo EL (1994) Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma: Endocrine Reviews 15: 356–368PubMedGoogle Scholar
  227. Epelbaum J, Bertherat J, Prevost G et al. (1995) Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metabol 80: 1837–1844CrossRefGoogle Scholar
  228. Grouzmann E, Gicquel C, Plouin PF, Schlumberger M et al. (1990) Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas. Cancer 66: 1833–1835PubMedCrossRefGoogle Scholar
  229. Hoefnagel CA (1994) Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 21: 561–581PubMedGoogle Scholar
  230. Invitti C, de Martin, Bolla GB, Pecori-Giraldi F et al. (1993) Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors. Hormone Res 40: 156–160PubMedCrossRefGoogle Scholar
  231. Isobe K, Nakai T, Yukimosa N, Nanmoku et al. Expression of mRNA coding for catecholamine synthesizing enzymes in human adrenal pheochromocytoma. Eur J Endocrinol 138: 1183–1187Google Scholar
  232. Janson ET, Oberg K (1993) Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon. Acta Oncol 32: 225–229Google Scholar
  233. Khosla S, Patel VM, Hay ID et al. (1991) Loss of heterozygositiy suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87: 1691–1699PubMedCrossRefGoogle Scholar
  234. Kopf D, Bockisch A, Steinert H, Hahn K et al. (1997) Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant pheochromocytoma. Clin Endocrinol 46: 39–44CrossRefGoogle Scholar
  235. Kubota A, Yamada Y, Kagimoto S et al. (1994) Identification of somatostatin receptor subtypes and implication for the efficacy of somatostatin analogue SMS 201–995 in treatment of human endocrine tumors. J Clin Invest 93: 1321–1325PubMedCrossRefGoogle Scholar
  236. Lehnert H (1998) Regulation of catecholamine synthesizing enzyme gene expression in human pheochromocytoma. Eur J Endocrinol 138: 363–367PubMedCrossRefGoogle Scholar
  237. Lindor NM Honchel R, Khosla S, Thibodeau SN (1995) Mutations in the RET protooncogene in sporadic pheochromocytomas. J Clin Endocrinol Metabol 80: 627–629CrossRefGoogle Scholar
  238. Mornex R, Badet C, Peyrin L (1992) Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990. J Endocrinol Invest 15: 643–649PubMedGoogle Scholar
  239. Nold R, Frank M, Kajdan U, Trost U (1994) Kombinierte Behandlung metastasierter endokriner Tumoren des Gastrointestinaltraktes mit Octreotid and Interferon-Alpha. Z Gastroenterol 32: 193–197PubMedGoogle Scholar
  240. Norton JA, Levin B, Jenson RT (1993) Cancer of the endocrine system. In: DeVita VT, Rosenberg SA, Hellman S eds. Cancer-principles and practice of oncology. Philadelphia: J B Lippincott Co: 1369–1371Google Scholar
  241. Oberg K, Eriksson B (1991) The role of interferons in the management of carcinoid tumours. Br J Haematol 79 Supplement 1: 74–77CrossRefGoogle Scholar
  242. Prevost G, Bourgeois Y, Mormont C et al. (1994) Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung xenograft: SCLC-6. Life Sciences 55: 155–162PubMedCrossRefGoogle Scholar
  243. Prove C, Vix M, Goropoulos A et al. (1992) High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 15: 651–663Google Scholar
  244. Reubi JC, Waser B, Khosla S et al. (1992) In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metabol 74: 1082–1089CrossRefGoogle Scholar
  245. O’Shea DB, Bloom S (1995) The use of somatostatin in the diagnosis and treatment of neuroendocrine tumors. Current opinion in endocrinology and diabets 2: 177180Google Scholar
  246. Tenenbaum F, Lumbroso J, Schlumberger M et al. (1995) Comparison of radiolabeled octreotide and metaiodobenzylguanidine ( MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36: 1–6Google Scholar
  247. Woodward ER, Eng C, McMahon R et al. (1997) Genetic predisposition to pheochromocytoma: analysis of candidate genes GDNF, RET and VHL. Human Molecular Genetics 6: 1051–1056Google Scholar
  248. Yamada Y, Kagimoto S, Kubota A et al. (1993) Cloning functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Comm 19: 844–852CrossRefGoogle Scholar
  249. Beckers A, Abs R, Willems PJ, Van der Auwera B, Kovacs K, Reznik M, Stevenaert A (1992) Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN 1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN 1 locus. J Clin Endocrinol Metab 75: 564–570PubMedCrossRefGoogle Scholar
  250. Conn JW (1955) Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3–17PubMedGoogle Scholar
  251. Doppman JL, Gill JR jr., Miller DL et al. (1992) Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 184: 677–682PubMedGoogle Scholar
  252. Dralle H (1989) Chirurgische Therapieverfahren. In: Hesch RD (Hrsg) Endokrinologie. Urban and Schwarzenberg, München, S 726–746Google Scholar
  253. Dralle H, Pichlmayr R (1991) Nebenniere. In: Pichlmayr R, Löhlein D (Hrsg) Chirurgische Therapie. Springer, Berlin Heidelberg New York, S 419–442Google Scholar
  254. Dralle H, Brabant G, Rose U, Schneyer U, Nashan B, Gerstenkorn C Kotzerke J (1996) Die Bedeutung bildgebender Verfahren für das operative Vorgehen bei Erkrankungen der Nebenniere. Acta Chir Austriaca 28: 292295Google Scholar
  255. Dralle H (1998) Nebenniere. In: Lippert H (Hrsg) Praxis der Chirurgie, Allgemein- und Viszeralchirurgie. Thieme, Stuttgart, 438–449Google Scholar
  256. Dunn JM, Farndon JR (1993) Hyperaldosteronism. Acta Chir Austriaca 25: 209–211CrossRefGoogle Scholar
  257. Favia G, Lumachi F, Scarpa V, D’Amico DF (1992) Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients. World J Surg 16: 680–684PubMedCrossRefGoogle Scholar
  258. Grant CS, Carpenter P, Van Heerden JA, Hamberger B (1984) Primary aldosteronism. Clinical management. Arch Surg 119: 85–590Google Scholar
  259. Groth H, Vetter W, Stimpel M, Greminger P, Tenschert W, Klaiber E, Vetter H (1985) Adrenalectomy in primary aldosteronism: a long-term follow-up study. Cardiology 72 /1: 107–116PubMedCrossRefGoogle Scholar
  260. Ito Y, Fujimoto Y, Obarat T, Kodama T (1990) Clinical significance of associated lesions of the adrenal in patients with aldosteronoma. World J Surg 14: 330–334PubMedCrossRefGoogle Scholar
  261. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16: 460–484PubMedGoogle Scholar
  262. Lo CY, Tam PC, Kung AWC, Lam KST, Wong J (1996) Primary aldosteronism. Results of surgical treatment. Ann Surg 224: 125–130Google Scholar
  263. Ludvik B, Niederle B, Roka R, Längle F, Neuhold N, Tempi M, Schernthaner G (1993) Isolated primary aldosteronism in adrenocortical carcinoma: a cese report and review of the literature. Acta Chir Austriaca 25: 212–216CrossRefGoogle Scholar
  264. Obara T, Ito Y, Fujimoto Y (1997) Hyperaldosteronism. In: Clark OH, Duh QY (eds) Textbook of Endocrine Surgery. Saunders, Philadelphia, 483–489Google Scholar
  265. Oelkers W, Dörr HG, Fehm HL, Müller OA (1993) Nebennierenrinde.Google Scholar
  266. In: Ziegler R, Pickardt CR, Willig RP (Hrsg) Rationelle Diagnostik in der Endokrinologie. Thieme, Stuttgart, S 148–151Google Scholar
  267. Stimpel M (1992) Therapie des primären Aldosteronismus. Dtsch Med Wschr 117: 947–949PubMedCrossRefGoogle Scholar
  268. Stimpel M, Dralle H, von zur Mühlen A (1986) Therapie des primären Aldosteronismus. Dtsch Med Wschr 11: 1487–1488CrossRefGoogle Scholar
  269. Young WF jr, Hogan MJ, Klee GG, Grant CS, Van Herden JA (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65: 96–110CrossRefGoogle Scholar
  270. Allolio B (1987) Diagnostik beim Cushing-Syndrom. Therapiewoche 37: 3068–3074Google Scholar
  271. Carney JA (1995) The carney complex (myxomas, spotty pigmentation, endocrine overactivity and schwannomas). Dermatol Clin 13: 19–26PubMedGoogle Scholar
  272. Findlay JC, Sheeler LR, Engeland WC et al. (1993) Familial adrenocorticotropin-independent Cushing’s syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 76: 189–191PubMedCrossRefGoogle Scholar
  273. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocrine Rev 16: 460–484Google Scholar
  274. Lacroix A, Bolté E, Tremblay J et al. (1992) Gastric inhibitory ploypeptide-dependent cortisol hypersecretion: a new cause of Cushing’s syndrome. N Engl J Med 327: 974–980PubMedCrossRefGoogle Scholar
  275. Malchoff CD, MacGillivray D, Malchoff DM (1996) Adrenocorticotropic hormone-independent adrenal hyperplasia. Endocrinologist 6: 79–85CrossRefGoogle Scholar
  276. Reincke M, Nieke J, Krestin GP, Saegeer W, Allolio B, Winkelmann W (1992) Preclinical Cushing’s syndrome in patients with adrenal „incidentalomas“: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 75: 826–832PubMedCrossRefGoogle Scholar
  277. Ross EJ, Marshall-Jones P, Friedman M (1966) Cushing’s syndrome: diagnostic criteria. Q J Med 35: 149–192PubMedGoogle Scholar
  278. Strohm M, Reincke M, Theiss M et al. (1994) Bilaterale massive makronoduläre Nebennierenhyperplasie: Eine seltene Ursache des adrenalen Cushing-Syndrom. Dtsch Med Wochenschr 119: 180–184Google Scholar
  279. Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P (1995) Abnormalities of endocrine function in patients with clinically „silent“ adrenal masses. Eur J Endocrinol 132: 422–428PubMedCrossRefGoogle Scholar
  280. Bencsik Z, Szabolccs I, G6th M et al. (1995) Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach. J Int Med 237: 585–589CrossRefGoogle Scholar
  281. Buell JF, Alexander R, Norton JA, Yu KC, Fraker DL (1997) Bilateral adrenalectomy for Cushing’s syndrome–anterior versus posterior surgical approach. Ann Surg 225: 63–68PubMedCrossRefGoogle Scholar
  282. Charbonnel B, Chatal JF, Ozanne P (1981) Does the corticoadrenal adenoma with „pre-Cushing’s syndrome“ exist ? J Nucl Med 22: 1059–1061PubMedGoogle Scholar
  283. Dal Bo Zanon R, Fornasiero L, Boscaro M, Cappellato G, Fabris F, Birolami A (1982) Increased factor VIII associated activities in Cushing’s syndrome: a probable hypercoagulable state. Thromb Haemost 47: 116–117Google Scholar
  284. Daitch JA, Goldfarb DA, Novick AC (1997) Cleveland Clinic experience with adrenal Cushing’s syndrome. J Urol 158: 2051–2055PubMedCrossRefGoogle Scholar
  285. Doherty GM, Niemann LK, Cutler GB Jr., Chrousos GP, Norton JA (1990) Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing’s syndrome. Surgery 108: 1085–1090PubMedGoogle Scholar
  286. Duh QY, Siperstein AE, Clark OH et al. (1997) Laparoscopic adrenalectomy–Comparison of the lateral and posterior approaches. Arch Surg 131: 870–876CrossRefGoogle Scholar
  287. Favia G, Boscaro M, Lumachi F, D’Amico DF (1994) Role of bilateral adrenalectomy in Cushing’s disease. World J Surg 18: 462–466PubMedCrossRefGoogle Scholar
  288. Fernandez-Cruz L, Saenz A, Bennaroch G, Astudillo E, Taura P, Sabater L (1996) Laparoscopic unilateral and bilateral adrenalectomy for Cushing’s syndrome–transperitoneal and retroperitoneal approaches. Ann Surg 224: 727–736PubMedCrossRefGoogle Scholar
  289. Gagner M (1996) Laparoscopic adrenalectomy. Surg Clin N Am 76: 523–537PubMedCrossRefGoogle Scholar
  290. Go H, Takeda M, lmai T, Komeyama T, Nishiyama T, Morishita H (1995) Laparoscopic adrenalectomy for Cushing’s syndrome: Comparison with primary aldosteronism. Surgery 117: 11–17Google Scholar
  291. Hamberger B, Russell CF, van Heerden JA et al. (1982) Adrenal Surgery: Trends during the seventies. Am J Surg 144: 523–526Google Scholar
  292. Imai T, Funahashi H, Tanaka Yet al. (1996) Adrenalectomy for treatment of Cushing syndrome: Results in 122 patients and long-term follow-up studies. World J Surg 20: 781–787PubMedCrossRefGoogle Scholar
  293. Linos DA (1997) Adrenaloma (Incidentaloma) In: Clark OH, Duh QY (eds): Textbook of endocrine surgery. WB Saunders Co. Philadelphia London Toronto Montreal Sydney Tokyo, pp 475–482Google Scholar
  294. Nies C, Bartsch D, Rothmund M (1994) Laparoskopische Cholecystektomie bei schwerer Adipositas–Indikation oder Kontraindikation? Chirurg 65: 29–32PubMedGoogle Scholar
  295. Nies C, Rothmund M (1995) Endoskopische Adrenalektomie–Indikationen, Technik, erste Ergebnisse. Acta Chir Austr 27: 256–263CrossRefGoogle Scholar
  296. Nies C, Möbius E, Rothmund M (1997) Laparoskopische Nebennierenchirurgie. Chirurg 68: 99–106PubMedCrossRefGoogle Scholar
  297. Plotz CM, Knowlton Al, Ragan C (1952) The natural history of Cushing’s syndrome. Amer J Med 13: 597–614PubMedCrossRefGoogle Scholar
  298. Reineke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W (1992) Preclinical Cushing’s syndrome in adrenal „incidentalomas“: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 75: 826832Google Scholar
  299. Ross NS (1994) Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin N Amer 23: 539–546Google Scholar
  300. Sarkar R, Thompson NW, Mcleod MK (1990) The role of adrenalectomy in Cushing’s syndrome. Surgery 108: 1079–1084PubMedGoogle Scholar
  301. Seppel T, Schlaghenke R (1996) Subklinischer Hypercortisolismus bei zufällig entdeckten Nebennierentumoren. Dtsch med Wschr 121: 503–508PubMedCrossRefGoogle Scholar
  302. Sjöberg HE, Blombäck M, Granberg PO (1976) Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing’s syndrome. Acta Med Scand 199: 95–98PubMedCrossRefGoogle Scholar
  303. Sonino N (1987) The use of Ketoconazole as an inhibitor of steroid production. N Engl J Med 317: 812–818PubMedCrossRefGoogle Scholar
  304. van Heerden JA, Young WF Jr., Grant CS, Carpenter PC (1995) Adrenal surgery for hypercortisolism–surgical aspects. Surgery 117: 466–472PubMedCrossRefGoogle Scholar
  305. Watson RGK, van Heerden JA, Northcutt RC, Grant CS, Ilstrup DM (1986) Results of adrenal surgery for Cushing’s syndrome: 10 years’ experience. World J Surg 10: 531–538PubMedCrossRefGoogle Scholar
  306. Arnott RD, Pastell RG, McKelvie PA, Henderson JK, McNeil PM, Alford FP (1990) A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing’s disease: prediction of outcome. Acta Endocrinol 123: 423–430PubMedGoogle Scholar
  307. Boggan JE, Tyrrell JB, Wilson CB (1983) Transsphenoidal microsurgical management of Cushing’s disease: Report of 100 cases. J Neurosurg 59: 195–200PubMedCrossRefGoogle Scholar
  308. Brunicardi FC, Rosman PM, Lesser KL, Andersen DK (1985) Current status of adrenalectomy for Cushing’s disease. Surgery 98: 1127–1133PubMedGoogle Scholar
  309. Chandler WF, Schteingart DE, Lloyd RV, McKeever PE, Ibarra-Perez G (1987) Surgical treatment of Cushing’s disease. J Neurosurg 66: 204–212PubMedCrossRefGoogle Scholar
  310. Clarke SD, Woo SY, Butler BE et al. (1992) Treament of secretory pituitary adenoma with radiation therapy. Radiology 188: 759–763Google Scholar
  311. Demeter JG, De Jong SA, Brooks MH, Lawrence AM, Paloyan E (1990) Long-term results of adrenal auto-transplantation in Cushing’s disease. Surgery 108: 1117–1123PubMedGoogle Scholar
  312. Fahlbusch R, Buchfelder M, Muller OA (1986) Transsphenoidal surgery for Cushing’s disease. J R Soc Med 79: 262–269PubMedGoogle Scholar
  313. Favia G, Boscaro M, Lumachi F, D’Amico DF (1994) Role of bilateral adrenalectomy in Cushing’s disease. World J Surg 18: 462–466PubMedCrossRefGoogle Scholar
  314. Favia G, Lumachi FN (1997) Cushing’s syndrome.In: Clark OH, Duh QY (eds): Textbook of endocrine surgery. WB Saunders Co. Philadelphia London Toronto Montreal Sydney Tokyo, pp 497–505Google Scholar
  315. Grabner P, Hauer-Jensen M, Jervell J, Flatmark A (1991) Long term results of treatment of Cushing’s disease by adrenalectomy. Eur J Surg 157: 461–464PubMedGoogle Scholar
  316. Hardy J (1969) Transspenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16: 185–217PubMedGoogle Scholar
  317. Hardy JD, Moore DO, Langford HG (1985) Cushing’s disease today–Late follow-up of 17 adrenalectomy patients with emphasis on eight with adrenal autotransplants. Ann Surg 201: 595–603PubMedCrossRefGoogle Scholar
  318. Imai T, Funahashi H, Tanaka Y et al. (1996) Adrenalectomy for treatment of Cushing syndrome: Results in 122 patients and long-term follow-up studies. World J Surg 20: 781–787PubMedCrossRefGoogle Scholar
  319. Kemink L, Pieters G, Hermus A, Smals A, Kloppenborg P (1994) Patient’s age is a simple predictive factor for the development of Nelson’s syndrome after total adrenalectomy for Cushing’s disease. J Clin Endocrinol Metab 79: 887–889PubMedCrossRefGoogle Scholar
  320. Mampalam TJ, Tyrrell JB, Wilson CB (1988) Transsphenoidal microsurgery for Cushing disease–A report of 216 cases. Ann Int Med 109: 487–493PubMedGoogle Scholar
  321. Nelson DH, Meakin JW, Thorn GW (1960) ACTH producing pituitary tumors following adrenalectomy for Cushing’s syndrome. Ann Int Med 52: 560–569PubMedGoogle Scholar
  322. Okamoto T, Obara T, Ito Yet al. (1996) Bilateral adrenalectomy with autotransplantation of adrenocortical tissue or unilateral adrenalectomy: treatment options forGoogle Scholar
  323. pheochromocytomas in multiple endocrine neoplasia type 2 A Endocr J 43: 169–175Google Scholar
  324. Salassa RM, Laws ER Jr., Carpenter PC, Northcutt RC (1978) Transsphenoidal removal of pituitary micro-adenoma in Cushing’s disease. Mayo Clin Proc 53: 24–28PubMedGoogle Scholar
  325. Watson RGK, van Heerden JA, Northcutt RC, Grant CS, Iistrup DM (1986) Results of adrenal surgery for Cushing’s syndrome: 10 years’ experience. World J Surg 10: 531–538PubMedCrossRefGoogle Scholar
  326. Welbourn RB (1985) Survival and causes of death after adrenalectomy for Cushing’s disease. Surgery 97: 16–20PubMedGoogle Scholar
  327. Xu YM, Chen ZD, Qiao Y, Jin NT (1992) The value of adrenal autotransplantation with attached blood vessels for the treatment of Cushing’s disease: A preliminary report. J Urol 147: 1209–1211Google Scholar
  328. Bertagna C, Orth DC (1981) Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center. Amer J Med 71: 835–875CrossRefGoogle Scholar
  329. Copeland PM (1983) The incidentally discovered adrenal mass. Ann Intern Med 98: 940–945.PubMedGoogle Scholar
  330. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21: 315–318PubMedCrossRefGoogle Scholar
  331. Hensen J, Buhl M, Oelkers W (1996) Diagnostisches und therapeutisches Vorgehen bei Patienten mit zufällig entdeckten Nebennierentumoren. In: Allolio B, Schulte HM (Hrsg): Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart, S 210–215Google Scholar
  332. Korobkin M, Brodeur FJ, Yutzy GG et al. (1990) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 166: 531–536Google Scholar
  333. Kley HK, Wagner H, Jaresch S, Jungbluth R, Schlaghecke R (1990) Endokrin inaktive Nebennierentumoren. In: Allolio B, Schulte HM (Hrsg) Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart, S 216–222Google Scholar
  334. Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: Evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171: 675–680Google Scholar
  335. Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G (1997) Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group. Horm Res 47: 284–289Google Scholar
  336. Reincke M, Allolio B (1995) Das Nebenniereninzidentalom: Die Kunst der Beschränkung in Diagnostik und Therapie. Dtsch Ärztebl 92: 764–770.Google Scholar
  337. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W (1992) Preclinical Cushing’s syndrome in patients with adrenal „incidentalomas“: comparison with adrenal Cushing’s syndrome. J Clin Endocr 75: 826–832PubMedCrossRefGoogle Scholar
  338. Ross NS, Aron DC (1990) Hormonal evaluations of the patient with an incidentally discovered adrenal mass. New Engl J Med 323: 1401–1405PubMedCrossRefGoogle Scholar
  339. Ant W, Reincke M, Winkelmann W, Allolio B (1990) Klinik and Therapie des Nebenniererindenkarzinoms. Therapiewoche 40: 2400–2406Google Scholar
  340. Bergenstal DM, Hertz R, Lipsett MB, Moy RH (1960) Chemotherapie of adrenocortical carcinoma with o,p’-DDD. Ann Intern Med 63: 672–682Google Scholar
  341. Berutti A, Terzolo M, Pia A, et al. (1998): Mitotane associated with etoposide, doxorubicin and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer 83 (10): 2194–2000CrossRefGoogle Scholar
  342. Bukowski R, Wolfe MM, Levine HS, Crawford DE, Stephens RL, Aynor E, Harker WG (1993) Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: A southwest oncology group study. J Clin Oncol 11: 161–165Google Scholar
  343. Didolkar MS, Beschwer RA, Elias EG, Moore RH (1981) Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients. Cancer 47: 21532161Google Scholar
  344. Hag MM, Legha SS, Samaan NA, Bodey GP, Burgess MA (1980) Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat 64: 909–913Google Scholar
  345. Johnson DH, Greco FA (1986) Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16). Cancer 58: 2198–2002PubMedCrossRefGoogle Scholar
  346. Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: Evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171: 675–680Google Scholar
  347. Lipsett MB, Hertz R, Ross GT (1963) Clinical and pathophysiologic aspects of adrenocortical carcinoma. Amer J Med 35: 374–383PubMedCrossRefGoogle Scholar
  348. Luton JP, Cerdas S, Billaud L et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. New Engl J Med 322: 11951201Google Scholar
  349. Markoe AM, Serber W, Micaily B, Brady LW (1991) Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Amer J Clin Oncol 14: 170–174CrossRefGoogle Scholar
  350. Nader S, Hickey RC, Sellin RV, Sammaan NA (1983) Adrenal cortical carcinoma. Cancer 52: 707–711PubMedCrossRefGoogle Scholar
  351. Reincke M (1998) Mutations in adrenocortical tumors. Horm Mebat Res 30: 417–455Google Scholar
  352. Sereide JA, Braband K, Thoresen SO (1992) Adrenal cortical carcinoma in Norway, 1970–1984. World J Surg 16: 663–668CrossRefGoogle Scholar
  353. Schlumberger M, Ostronoff M, Bellaiche M, Rougier P, Droz JP, Parmentier C (1988) 5-Flurouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma. Cancer 61: 1492–1494Google Scholar
  354. Cahill PJ, Sukov RJ (1977) Inferior vena cava involvement by adrenal cortical carcinoma. Urology 10: 604–607PubMedCrossRefGoogle Scholar
  355. Gröndal S, Cedermark B, Ericksson B et al. (1990) Adrenocortical carcinoma: A retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 16: 500–506Google Scholar
  356. Hedican SP, Marshall FF (1997) Adrenocortical carcinoma with intracaval extension. J Urol 158: 2056–2061PubMedCrossRefGoogle Scholar
  357. lcard P, Chapuis Y, Andreassian B, Bernard A, Proye C (1992) Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French association of endocrine surgery. Surgery 112: 972–980Google Scholar
  358. Icard P, Louvel A, Chapuis Y (1992a) Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 16: 753–758PubMedCrossRefGoogle Scholar
  359. Jensen JC, Pass HI, Sindelar WF, Norton JA (1991) Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Arch Surg 126: 457–461PubMedCrossRefGoogle Scholar
  360. Khorram-Manesh A, Ahlman II, Jansson S et al. (1998) Adrenocortical carcinoma: Surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22: 605–612Google Scholar
  361. Luton JP, Cerdas S, Billaud L et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322: 1195–1201PubMedCrossRefGoogle Scholar
  362. Nies C, Möbius E, Rothmund M (1997) Laparoskopische Nebennierenchirurgie. Chirurg 68: 99–106PubMedCrossRefGoogle Scholar
  363. Pommier RF, Brennan MF (1991) An eleven-year experience with adrenocortical carcinoma. Surgery 112: 963–971Google Scholar
  364. Siegelbaum MH, Moulsdale JE, Murphy JB, McDonald GR (1993) Use of magnetic resonance imaging scanning in adrenocortical carcinoma with vena caval involvement. Urology 43: 869–873CrossRefGoogle Scholar
  365. Soreide JA, Braband K, Thoresen SO (1992) Adrenal cortical carcinoma in Norway, 1970–1984. World J Surg 16: 663–668PubMedCrossRefGoogle Scholar
  366. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA (1989) Adrenal cortical carcinoma. Cancer 64: 765–769PubMedCrossRefGoogle Scholar
  367. Allolio B, Kaulen D, Deuß U, Hipp FX, Winkelmann W (1985) Vergleich von Hydrocortison und Cortisonacetat in der Substitutionstherapie der Nebennierenrindeninsuffizienz. Akt Endokr Stoffw 6: 35–39Google Scholar
  368. Allolio B, Rosenthal C, Schulte HM (1990) Überwachung der Substitutionstherapie bei Nebennierenrinden(NNR)-Insuffizienz. In: Allolio B, Schulte HM (Hrsg): Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer, Stuttgart New YorkGoogle Scholar
  369. Arlt W, Justl HG, Callies F et al. (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharma-Google Scholar
  370. cokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83 (im Druck)Google Scholar
  371. Ahonen P, Myllarnieme S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy. NEJM 322: 18291936Google Scholar
  372. Betterle C, Greggio NA, Volpato M (1998). Clinical Review: Autoimmune polyglandular syndrome Typ I. J Clin Endocrinol Metab 83: 1049–1055Google Scholar
  373. Buxi TB, Vohra RB, Sujatha B et al. (1992) CT in adrenal enlargement due to tuberculosis: a review of the literature with five new cases. Clin Imaging 16: 102–108PubMedCrossRefGoogle Scholar
  374. Esteban NV, Loughlin T, Yergey AL et al. (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72: 39–45PubMedCrossRefGoogle Scholar
  375. Grinspoon SK, Biller BMK (1994) Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 79: 923–931Google Scholar
  376. Irvine WJ, Barnes EW (1972) Adrenocortical insufficiency. Clin Endocrinol Metab 1: 549–594CrossRefGoogle Scholar
  377. Kong MF, Jeffcoate W (1994). Eighty-six cases of Addison’s disease. Clin Endocrinol 41: 757–761CrossRefGoogle Scholar
  378. Morales AJ, Nolan JJ, Nelson JC et al. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78: 1360–1367PubMedCrossRefGoogle Scholar
  379. Moser HW (1995). Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy. J Neuropathol Exp Neurol 54: 740–745PubMedCrossRefGoogle Scholar
  380. Nagamine K, Peterson P, Scott HS et al. (1997) Positional cloning of the APECED gene. Nat Genet 17: 393–398PubMedCrossRefGoogle Scholar
  381. Nerup J (1974) Addison’s disease–clinical studies. A report of 108 cases. Acta Endocrinologica 76: 127–141PubMedGoogle Scholar
  382. Neufeld M, Maclaren NK, Blizzard RM (1981) Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune ( PGA) syndromes. Medicine (Baltimore) 60: 355–362Google Scholar
  383. Oelkers W (1996a). Current concepts: Adrenal insufficiency. NEJM 335: 1206–1212PubMedCrossRefGoogle Scholar
  384. Oelkers W (1996b). Dose response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low dose adrenocorticotropin test. Eur J Endocrinol 135: 27–33PubMedCrossRefGoogle Scholar
  385. Piedrola G, Casado JL, Lopez E et al. (1996) Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endocrinol 45: 97–101Google Scholar
  386. Stewart PM, Corrie J, Seckl JR et al. (1988) A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet: 1208–1210Google Scholar
  387. Uibo R, Aavik E, Petersen P et al. (1994) Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab 78: 323–328PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • B. Allolio
  • P. J. Barth
  • H. Dralle
  • O. Gimm
  • B. Hamberger
  • J. Klose
  • H. Lehnert
  • A. Machens
  • R. Moll
  • J. Mundschenk
  • C. Nies
  • M. Reincke

There are no affiliations available

Personalised recommendations